These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10601800)

  • 1. Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32.
    Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
    Chemotherapy; 2000; 46(1):69-76. PubMed ID: 10601800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line.
    Mese H; Sasaki A; Nakayama S; Alcalde RE; Matsumura T
    Cancer Chemother Pharmacol; 2000; 46(3):241-5. PubMed ID: 11021742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
    Raffo AJ; Kim AL; Fine RL
    Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.
    Kim R; Ohi Y; Inoue H; Toge T
    Anticancer Res; 2000; 20(1A):439-44. PubMed ID: 10769693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
    Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
    Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell.
    Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
    Chemotherapy; 1998; 44(6):414-20. PubMed ID: 9755302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.
    Biroccio A; Benassi B; Amodei S; Gabellini C; Del Bufalo D; Zupi G
    Mol Pharmacol; 2001 Jul; 60(1):174-82. PubMed ID: 11408612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of p53 Phosphorylation at Serine 20 by Resveratrol Is Required to Activate p53 Target Genes, Restoring Apoptosis in MCF-7 Cells Resistant to Cisplatin.
    Hernandez-Valencia J; Garcia-Villa E; Arenas-Hernandez A; Garcia-Mena J; Diaz-Chavez J; Gariglio P
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro establishment of cis-diammine-dichloroplatinum(II) resistant lung cancer cell line and modulation of apoptotic gene expression as a mechanism of resistant phenotype.
    Yoon SS; Ahn KS; Kim SH; Shim YM; Kim J
    Lung Cancer; 2001; 33(2-3):221-8. PubMed ID: 11551417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
    Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDDP induces p53-dependent apoptosis in tongue cancer cells.
    Kanata H; Yane K; Ota I; Miyahara H; Matsunaga T; Takahashi A; Ohnishi K; Ohnishi T; Hosoi H
    Int J Oncol; 2000 Sep; 17(3):513-7. PubMed ID: 10938392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation.
    Mansouri A; Zhang Q; Ridgway LD; Tian L; Claret FX
    Oncol Res; 2003; 13(6-10):399-404. PubMed ID: 12725530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of growth-inhibitory effect of cisplatin on human pancreatic cancer cells and status of p53 gene.
    Seki T; Ohba N; Makino R; Funatomi H; Mitamura K
    Anticancer Res; 2001; 21(3B):1919-24. PubMed ID: 11497278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
    Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
    Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
    Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.